This is not the most recent version of the article. View current version (18 SEP 2014)

Intervention Review

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

  1. Vicente Ruiz Garcia1,*,
  2. Paresh Jobanputra2,
  3. Amanda Burls3,
  4. Juan B Cabello4,
  5. José G Gálvez Muñoz5,
  6. Encarnación SC Saiz Cuenca6,
  7. Anne Fry-Smith7

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 16 FEB 2011

Assessed as up-to-date: 31 DEC 2009

DOI: 10.1002/14651858.CD007649.pub2


How to Cite

Ruiz Garcia V, Jobanputra P, Burls A, Cabello JB, Gálvez Muñoz JG, Saiz Cuenca ESC, Fry-Smith A. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD007649. DOI: 10.1002/14651858.CD007649.pub2.

Author Information

  1. 1

    Hospital La Fe Valencia, Unidad de Hospitalización a Domicilio & CASP Spain, Valencia, Valencia, Spain

  2. 2

    University Hospitals Birmingham NHS Foundation Trust, Department of Rheumatology, Selly Oak, Birmingham, UK

  3. 3

    University of Oxford, Department of Primary Health Care, Oxford, Birmingham, UK

  4. 4

    Hospital General Universitario de Alicante, Departamento de Cardiologia & CASP Spain, Alicante, Alicante, Spain

  5. 5

    Servicio Murciano de Salud, Hospital Morales Meseguer, Rheumatology Unit, Murcia, Murcia, Spain

  6. 6

    Servicio Murciano de Salud, Hospital Morales Meseguer, Rheumatoid Arthritis Unit, Murcia, Murcia, Spain

  7. 7

    University of Birmingham, Department of Public Health & Epidemiology, Birmingham, UK

*Vicente Ruiz Garcia, Unidad de Hospitalización a Domicilio & CASP Spain, Hospital La Fe Valencia, Avda de Campanar 21, Valencia, Valencia, 46009, Spain. vicenteruizgarcia@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 16 FEB 2011

SEARCH

This is not the most recent version of the article. View current version (18 SEP 2014)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.